Origin Agritech to Host First Half 2022 Earning Conference Call
BEIJING, April 14, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today announced that it will file its first half 2022 financial results on Thursday, May 5, 2022 before the market open and will host a conference call that same day at 8:00 AM ET. Participants may dial into the call as follows:Domestic...
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
Insilico Medicine Nominates Its USP1 Small Molecule Inhibitor as a Preclinical Candidate for Tumors with Homologous Recombination Deficiency NEW YORK, April 13, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that the company completed the experimental validation of AI-designed molecules with the desired properties and nominated the preclinical candidate...
LIMACORPORATE ANNOUNCES LEADERSHIP TRANSITION AND APPOINTMENT OF INTERIM CEO
UDINE, Italy, April 13, 2022 /PRNewswire/ -- LimaCorporate S.p.A., a leading global orthopedic manufacturer focused on digital innovation and tailored hardware, today announces that Luigi Ferrari, Chief Executive Officer of LimaCorporate, will be stepping down from the role of CEO, to pursue new activities outside of the organization. Mr. Ferrari has led...
European Wellness Signs MOU in Dubai Expo 2020 to Strengthen Medical Tourism into Malaysia and Develop Advanced Biological Regenerative Medicine in UAE
DUBAI, UAE, April 13, 2022 /PRNewswire/ -- European Wellness Biomedical Group (EW Group), through its Malaysian subsidiary European Wellness Academie, and Dubai- based healthcare distribution and technology group, AK International LLC, have signed a Memorandum of Understanding (MOU) on 30th March 2022 that aims to strengthen the medical tourism linkages and access to Biological Regenerative Medicine...
Ascletis Announces Cooperation with China Meheco International Co., Ltd. in Distribution of Its Ritonavir Tablets in Chinese Mainland
HANGZHOU, China and SHAOXING, China, April 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Ascletis Pharmaceuticals Co., Ltd. ("Ascletis Pharmaceuticals") has signed an agreement with China Meheco International Co., Ltd. for distribution of its ritonavir tablets in Chinese mainland. Ascletis Pharmaceuticals is a wholly-owned subsidiary of Ascletis, and China Meheco International Co., Ltd. is...
Happiness Development Donated Anti-epidemic Materials to Minhang District, Shanghai
NANPING, China, April 13, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that the Company has donated RMB 200,000 worth of anti-epidemic materials such as...
Omega Healthcare completes acquisition of ApexonHealth and Vasta Global
BOCA RATON, Fla., April 13, 2022 /PRNewswire/ -- Omega Healthcare, a leading technology-enabled healthcare management solutions provider, today announced its acquisition of ApexonHealth, an AI and automation-based revenue cycle management and payor solutions provider, and Vasta Global, a provider of real-world data abstraction and analytics for the oncology market. ApexonHealth leverages its...
Oncoshot Enters Into MOU With Singapore Clinical Research Institute
SINGAPORE, April 13, 2022 /PRNewswire/ -- Oncoshot has signed a memorandum of understanding with the Singapore Clinical Research Institute (SCRI), the national coordinating body for clinical trials under the newly launched Consortium for Clinical Research and Innovation Singapore (CRIS). The signing event held last Wednesday was witnessed by guest-of-honour Minister for Health Mr Ong Ye Kung. Left to...
Seed Expands into Children’s Health with Launch of Its First Clinically Studied Pediatric Synbiotic
PDS-08™ reflects Seed's mission to bring scientific rigor, efficacy, and novel data generation to the global category of probiotics LOS ANGELES, April 13, 2022 /PRNewswire/ -- Seed, the microbiome science company pioneering clinically and scientifically studied next-generation probiotics, today launched its first pediatric innovation, PDS-08™ Pediatric Daily Synbiotic, a clinically studied, two-in-one powdered synbiotic formulated for children and adolescents (ages 3 to...
111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai’s Fight Against Covid-19 Pandemic
SHANGHAI, April 13, 2022 /PRNewswire/ -- On April, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, has set up an "Anti-Epidemic Command" at the first opportunity to coordinate its relevant departments and manpower to fully participate in the fight against the pandemic in Shanghai. As a provider of anti-epidemic items...
